MOA Life Plus Co. Ltd. (KOSDAQ:142760)
655.00
-6.00 (-0.91%)
At close: Mar 13, 2026
MOA Life Plus Market Cap
MOA Life Plus has a market cap or net worth of 26.73 billion as of March 13, 2026. Its market cap has decreased by -43.96% in one year.
Market Cap
26.73B
Enterprise Value
26.27B
Revenue
9.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
655.00
Market Cap Chart
Since July 7, 2016, MOA Life Plus's market cap has decreased from 97.39B to 26.73B, a decrease of -72.55%. That is a compound annual growth rate of -12.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 26.73B | -61.44% |
| Dec 30, 2025 | 69.32B | 51.95% |
| Dec 30, 2024 | 45.62B | -33.64% |
| Dec 28, 2023 | 68.75B | -38.77% |
| Dec 29, 2022 | 112.27B | -53.08% |
| Dec 30, 2021 | 239.30B | 38.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SunBio,Inc. | 61.21B |
| Aptamer Sciences | 56.28B |
| NGeneBio | 56.02B |
| J2KBIO | 45.14B |
| SCM Lifescience | 37.79B |
| ADBiotech | 37.78B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |